Innovating Works

TSE

Desconocido
INSPIRE: INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse... TSE SYSTEMS GMBH participó en un H2020: H2020-MSCA-ITN-2019 New drug candidates often have off-target effects resulting in adverse events, thus representing a major limitation for drug R&D. Safety Pha...
2019-08-19 - 2024-05-31 | Financiado
IDT: The IntelliDogTrainer a new high throughput training device to train high level security dogs TSE SYSTEMS GMBH tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Recently the threat of terroristic attacks dramatically increased. Therefore, global demand of bomb-sniffing dogs surged up to an unpreceden...
2018-07-09 - 2019-01-31 | Financiado
INFRAFRONTIER2020: Towards enduring mouse resources and services advancing research into human health and disease TSE SYSTEMS GMBH participó en un H2020: H2020-INFRADEV-2016-2017 The INFRAFRONTIER RI integrates European Mouse Clinics and the European Mouse Mutant Archive with the common goal to ensure access to mouse...
2016-12-14 - 2021-12-31 | Financiado
INFRAFRONTIER-I3: Development of mouse mutant resources for functional analyses of human diseases Enhancing the tran... TSE SYSTEMS GMBH participó en un FP7: The mouse shows great similarities in development, physiology and biochemistry to humans, which makes it a key model for research into human...
Financiado
PHENOSCALE: Large scale high throughput automated systems for phenotyping mouse models of human disease TSE SYSTEMS GMBH participó en un FP7: We are now entering an era of genomic exploration. The mouse is a pre-eminent model not only to map all mammalian genes, but to determine th...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.